A Descriptive Study of Quality of Life Following Neoadjuvant Chemotherapy and Transoral Robotic Surgery for Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma.
Alina DiaconescuJennifer A SilverThava SubramaniamMaida J SewitchMarco A MascarellaJose Ramirez-Garcia LunaNahid GolabiKeith RichardsonNathaniel BouganimReza ForghaniAlex Marcin MlynarekMichael P HierNader SadeghiPublished in: Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale (2024)
In HPV-related OPSCC, neoadjuvant chemotherapy followed by TORS and ND as definitive treatment is associated with excellent QOL outcomes. Postoperative QOL scores returned to baseline by 3 months and were maintained for all measures, indicating a return to normal function.